191 related articles for article (PubMed ID: 21368600)
1. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
[TBL] [Abstract][Full Text] [Related]
2. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
Gandhi S; Abhyankar A; Basu S
Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
[TBL] [Abstract][Full Text] [Related]
3. Should we routinely offer a second admission for radioiodine to patients with high-risk differentiated thyroid cancer?
Gerrard GE; O'Toole L; Roberts F
Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):136-9. PubMed ID: 20152708
[TBL] [Abstract][Full Text] [Related]
4. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.
Bhattacharyya N; Chien W
Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):607-10. PubMed ID: 16944659
[TBL] [Abstract][Full Text] [Related]
5. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
[TBL] [Abstract][Full Text] [Related]
6. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
Dottorini ME; Lomuscio G; Mazzucchelli L; Vignati A; Colombo L
J Nucl Med; 1995 Jan; 36(1):21-7. PubMed ID: 7799075
[TBL] [Abstract][Full Text] [Related]
7. Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases.
Higashi T; Nishii R; Yamada S; Nakamoto Y; Ishizu K; Kawase S; Togashi K; Itasaka S; Hiraoka M; Misaki T; Konishi J
J Nucl Med; 2011 May; 52(5):683-9. PubMed ID: 21498534
[TBL] [Abstract][Full Text] [Related]
8. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
de Vathaire F
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
[No Abstract] [Full Text] [Related]
9. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
[TBL] [Abstract][Full Text] [Related]
11. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
12. Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
Cappagli V; Caldarella A; Manneschi G; Piaggi P; Bottici V; Agate L; Molinaro E; Bianchi F; Elisei R
Int J Cancer; 2020 Nov; 147(10):2838-2846. PubMed ID: 32449158
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
Marti JL; Jain KS; Morris LG
Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
[TBL] [Abstract][Full Text] [Related]
15. Second neoplasms after megavoltage radiation for pediatric tumors.
Gold DG; Neglia JP; Dusenbery KE
Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma.
Fard-Esfahani A; Hadifar M; Fallahi B; Beiki D; Eftekhari M; Saghari M; Takavar A
Hell J Nucl Med; 2009; 12(1):37-40. PubMed ID: 19330181
[TBL] [Abstract][Full Text] [Related]
17. The risk of multiple primary breast and thyroid carcinomas.
Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
[TBL] [Abstract][Full Text] [Related]
18. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation.
Kim EY; Kim WG; Kim WB; Kim TY; Ryu JS; Gong G; Yoon JH; Hong SJ; Lee JH; Baek JH; Shong YK
Clin Endocrinol (Oxf); 2010 Aug; 73(2):257-63. PubMed ID: 20105187
[TBL] [Abstract][Full Text] [Related]
20. Aspects of timing and selection of cases in radioiodine therapy and percutaneous irradiation of well differentiated carcinoma of the thyroid.
Wiebe V; Schneider C; Franke HD
Strahlentherapie; 1975 Jan; 149(1):55-9. PubMed ID: 1124555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
